Vinorelbine
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy (NCT04848454) | Peking University First Hospital | 2021-11-20 |
| Vinorelbine for Recurrent ACLC (NCT03397953) | Children's Cancer Group, China | 2016-11-01 |
| Vinorelbine for Recurrent ALCL-2017 (NCT03443128) | Children's Cancer Group, China | 2016-11-01 |
Track Vinorelbine automatically
Every clearance here is in the API, with alerts when new ones post.